PACIRA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +4.69% |
|
+5.46% | -6.67% |
| May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
| May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
Chart calendar Pacira BioSciences, Inc.
97989cb8ded14c.7R5Ug9Ji_5Ch5lxt0hVzn1mwv5r1u5JbibqyqkPbdUs.nVIAzJVUsOCV1SQDmyUy2zz58PvHycFt3_WH2jDjJSGufBe2kVWl5OqqMw~3b08bc7aabb28727bb992b4c3802b401
Upcoming events on Pacira BioSciences, Inc.
Past events on Pacira BioSciences, Inc.
| 2024-05-14 10:30 am | RBC Capital Markets Global Healthcare Conference |
| 2024-05-07 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-07 04:00 pm | Q1 2024 Earnings Release |
| 2024-04-08 08:00 am | Needham Healthcare Conference |
| 2024-03-13 01:35 pm | Barclays Global Healthcare Conference |
| 2024-02-29 08:30 am | Q4 2023 Earnings Call |
| 2024-02-29 08:00 am | Q4 2023 Earnings Release |
| 2024-01-10 11:15 am | JPMorgan Healthcare Conference |
| 2023-11-28 02:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-14 06:00 am | Jefferies London Healthcare Conference |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 08:00 am | Q3 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-02 08:30 am | Q2 2023 Earnings Call |
| 2023-08-02 08:00 am | Q2 2023 Earnings Release |
| 2023-06-13 02:00 pm | Annual General Meeting |
| 2023-06-07 09:30 am | Jefferies Global Healthcare Conference |
| 2023-05-16 03:05 pm | RBC Global Healthcare Conference |
| 2023-05-03 08:30 am | Q1 2023 Earnings Call |
| 2023-05-03 08:00 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 421 421 0.09% | 430 430 0.01% | 542 536 0.95% | 667 668 -0.21% | 675 675 0.07% | 695 |
|
EBITDA Million USD | Released Forecast Spread | 94,9 85,0 11.65% | 113 134 -16.1% | 204 190 7.49% | 213 224 -4.97% | 214 216 -0.81% | 214 |
|
EBIT Million USD | Released Forecast Spread | 75,3 71,0 5.99% | 99,3 100 -0.89% | 189 175 8.12% | 195 204 -4.54% | 198 199 -0.53% | 187 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -1,50 -615.58% | 20,1 29,6 -32.06% | 56,4 110 -48.5% | 13,3 52,5 -74.69% | 61,7 55,2 11.7% | 81,4 |
|
Net income Million USD | Released Forecast Spread | -11,0 -0,28 -3768.66% | 146 152 -4.22% | 42,0 71,2 -41.05% | 15,9 41,9 -62% | 42,0 40,8 2.82% | 58,6 |
|
EPS USD | Released Forecast Spread | -0,27 -0,01 -3500% | 3,33 3,41 -2.35% | 0,92 1,59 -42.21% | 0,34 0,84 -59.4% | 0,89 0,82 8.27% | 1,22 |
| Announcement Date | 20/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 158 155 1.88% | 169 169 0.08% | 167 168 -0.03% | 172 173 -0.79% | 160 159 0.58% | 169 175 -3.15% | 164 173 -5.2% | 181 181 0.23% | 167 166 0.87% | 173 | 172 | 183 | 182 | 191 |
|
EBITDA Million USD | Released Forecast Spread | 53,8 60,2 -10.51% | 44,9 65,5 -31.46% | 55,2 64,4 -14.17% | 58,8 69,1 -15.01% | 41,9 50,1 -16.3% | 54,3 60,7 -10.59% | 52,9 57,4 -7.76% | 65,4 63,2 3.51% | 44,6 45,3 -1.64% | 52,1 | 51,1 | 61,8 | 56,6 | 63,2 |
|
EBIT Million USD | Released Forecast Spread | 49,2 53,9 -8.71% | 40,9 58,0 -29.48% | 50,8 56,9 -10.81% | 54,0 61,4 -12.11% | 37,4 44,6 -16.05% | 50,3 52,8 -4.79% | 49,2 51,5 -4.32% | 60,7 60,1 1.06% | 40,6 43,6 -6.74% | 47,1 | 44,9 | 54,8 | 57,3 | 65,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7,29 26,2 -72.21% | 22,0 33,1 -33.47% | 2,07 25,1 -91.76% | -18,1 21,2 -185.32% | -26,5 9,47 -379.5% | 37,9 19,0 99.64% | 16,6 22,8 -27.26% | 33,7 27,3 23.7% | 13,6 18,7 -27.08% | 20,4 | 22,3 | 25,0 | 20,8 | 27,2 |
|
Net income Million USD | Released Forecast Spread | 6,83 22,2 -69.23% | 19,9 24,1 -17.62% | -0,69 17,8 -103.88% | -10,1 15,9 -163.73% | -19,5 6,84 -385.81% | 25,8 11,0 133.52% | 10,9 16,5 -34.02% | 24,9 20,5 21.27% | 8,98 12,8 -29.91% | 15,2 | 14,4 | 19,9 | 15,0 | 19,6 |
|
EPS USD | Released Forecast Spread | 0,15 0,43 -65.44% | 0,40 0,50 -20.4% | -0,02 0,35 -105.71% | -0,22 0,32 -169.29% | -0,43 0,14 -418.52% | 0,51 0,23 119.35% | 0,23 0,33 -29.77% | 0,50 0,41 21.95% | 0,19 0,23 -17.39% | 0,31 | 0,28 | 0,40 | 0,31 | 0,40 |
| Announcement Date | 04/05/22 | 03/08/22 | 03/11/22 | 28/02/23 | 03/05/23 | 02/08/23 | 02/11/23 | 29/02/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Pacira BioSciences, Inc.
| Today | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| Today | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 am | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 05:43 pm | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 am | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 am | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PCRX Stock
- Calendar Pacira BioSciences, Inc.
